1-500 | 501-700
    Part,  Chapter, Paragraph

  1    I,     2. 11        |                  Gesler, W., Preisser, J., Sherman, J., Spencer,
  2    I,     2. 11        |                 Preisser, J., Sherman, J., Spencer, J., Perin, J. (
  3    I,     2. 11        |                  Sherman, J., Spencer, J., Perin, J. (2005): The
  4    I,     2. 11        |                J., Spencer, J., Perin, J. (2005): The effects of
  5    I,     2. 11        |            indigenous populations. Int J Circumpolar Health. 2007
  6    I,     2. 11        |              113(7), 823-839.~Rantanen J (1998): The changing world
  7    I,     2. 11        |                R, Tsolova S, Mortensen J (2005): The impact of health
  8    I,     3.  4        |            Haag.~ ~Bloom D E, Trussell J (1984): What Are the Determinants
  9    I,     3.  4        |                en Europe, in A. Blum e J. L. Rallu (eds) Démographie
 10   II,     4.  3        |           Health and Welfare.~ ~Riley, J. C. (1990): The risk of
 11   II,     4.  3        |              16(3): 403-432.~ ~Robine, J.-M. and C. Jagger (2007):
 12   II,     4.  3        |            Ashgate: 317-328.~ ~Robine, J.-M. and C. Jagger (2007):
 13   II,     4.  3        |          Montpellier, Inserm~ ~Robine, J.-M., C. Jagger, et al. (
 14   II,     4.  3        |               1-2): 119-133.~ ~Robine, J.-M., C. Jagger, et al. (
 15   II,     4.  3        |          Health 13(3): 6-14.~ ~Robine, J.-M., C. Jagger, et al.,
 16   II,     4.  3        |               2003; 13:6-14.~ ~Robine, J.-M., C. Jagger, et al. (
 17   II,     4.  3        |             LVII(2): 89-101.~ ~Robine, J.-M., S. Le Roy, et al. (
 18   II,     4.  3        |                 EHEMU: 9-48.~ ~Robine, J.-M. and J.-P. Michel (2004):
 19   II,     4.  3        |                48.~ ~Robine, J.-M. and J.-P. Michel (2004): Looking
 20   II,     4.  3        |          Services: 34.~ ~Van Oyen, H., J. van der Heyden, et al. (
 21   II,     5.  2.  4    |         reduced CVD incidence (Wellman J, 2004).~Due to differences
 22   II,     5.  2.  6    |       epidemiological studies (Stamler J et al, 1986). The association
 23   II,     5.  2.  6    |             Framingham Study. Am Heart J 110: 1100-1107.~Kannel WB (
 24   II,     5.  2.  6    |                Zutphen Elderly Study). J Hypertens 14: 1159-1166.~
 25   II,     5.  2.  6    |               R, Sherliker P, Emberson J, Halsey J, Qizilbash N,
 26   II,     5.  2.  6    |        Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins
 27   II,     5.  2.  6    |              meta-regression analysis. J Am Coll Cardiol 46: 1855-
 28   II,     5.  2.  6    |         Cardiol 46: 1855-1862.~Stamler J, Wentworth D, Neaton JD (
 29   II,     5.  2.  6    |         cardiovascular disease. N Engl J Med 345: 1291-1297.~ ~
 30   II,     5.  2.  7    |        Bruxelles.~Daviglus ML, Stamler J, Pirzada A et al (2004):
 31   II,     5.  2.  7    |                Dyer AR, Wang R, Lubitz J et al (2005): Cardiovascular
 32   II,     5.  2.  7    |              the EUROCISS Project. Eur J Public Health 13: 55-60~
 33   II,     5.  2.  7    |                WHO MONICA Project. Int J Epidemiol 30 (1):S35-S40.~
 34   II,     5.  2.  7    |         Italian population samples. Am J Epid 163(10): 893-902.~Gra ).
 35   II,     5.  2.  7    |           executive summary. Eur Heart J 28: 2375-414~Greenland P,
 36   II,     5.  2.  7    |         Greenland P, Knoll MD, Stamler J,. Neaton JD, Dyer AR,. Garside
 37   II,     5.  2.  7    |        Treatment Panel III Guidelines. J Am Coll Cardiol 44: 720-
 38   II,     5.  2.  7    |               1970 and 2000. Eur Heart J 27: 107-113.~Kuulasmaa K,
 39   II,     5.  2.  7    |                 Ferrario M, Tuomilehto J (2000): Estimation of contribution
 40   II,     5.  2.  7    |        Chiodini P, Sega R, and Stamler J (2006): Favorable cardiovascular
 41   II,     5.  2.  7    |                the Progetto CUORE. Eur J Cardiovasc Prev Rehabil
 42   II,     5.  2.  7    |                R, Giampaoli S, Stamler J (2008): Preventive potential
 43   II,     5.  2.  7    |              study [htt rg/doi:10.1016/j.ypmed.2008.01.023] (accessed
 44   II,     5.  2.  7    |                 Peto V, Rayner M, Leal J, Luengo-Fernandez R and
 45   II,     5.  2.  7    |               Vartiainen E, Tuomilehto J, Salomaa V, Nissinn A (1998):
 46   II,     5.  2.  7    |   Collaborative Research Group. N Engl J Med 344: 3-10.~Sans S, Kesteloot
 47   II,     5.  2.  7    |        statistics in Europe. Eur Heart J 18: 1231–48.~Sarti C, Stegmayr
 48   II,     5.  2.  7    |               H, MAhonen M, Tuomilehto J, Asplund K, for the WHO
 49   II,     5.  2.  7    |         disease: rates and trends. Int J Epidemiol 18 (suppl):S20–
 50   II,     5.  2.  7    |       countries from 1950 to 1978. Int J Epidemiol14: 510-20.~Tolonen
 51   II,     5.  2.  7    |               K, Vanuzzo D, Tuomilehto J for the WHO MONICA Project (
 52   II,     5.  2.  7    |               and Wales, 1981-2000. Am J Public Health 95 (1): 103-
 53   II,     5.  2.  7    |                Budaj A, Pais P, Varigo J, Lisheng A (2004): Effect
 54   II,     5.  3.  9    |                G, Verdecchia A, Estève J, Sant M, Storm H, Allemani
 55   II,     5.  3.  9    |               9th June 2008).~ ~Ferlay J, Autier P, Boniol M, Heanue
 56   II,     5.  3.  9    |              nine prospective studies. J Natl Cancer Inst 94:606-
 57   II,     5.  3.  9    |          cancer health indicators. Eur J Public Health 13(3 Suppl):
 58   II,     5.  3.  9    |              Parkin DM, Bray F, Ferlay J, Pisani P (2005): Global
 59   II,     5.  3.  9    |            statistics, 2002. CA Cancer J Clin 55(2):74-108.~ ~Sant
 60   II,     5.  3.  9    |              Lasota M, Carli P, Faivre J, Grosclaude P, Hédelin G,
 61   II,     5.  3.  9    |             screening in Japan. N Engl J Med 350: 2010-1~ ~Verdecchia
 62   II,     5.  4.  1    |         history of diabetes is 'U' or 'J' shaped with relatively
 63   II,     5.  4.  8    |                29, OECD 2006~Azzopardi J, Fenech FF, Junoussov Z,
 64   II,     5.  4.  8    |           Gudbjörnsdottir S, Cederholm J, Nilsson PM, Eliasson B;
 65   II,     5.  4.  8    |             myocardial infarction? Int J Clin Pract 61(4):680-3~Jönsson
 66   II,     5.  4.  8    |              Nystrom L, Wall S, Ostman J., Excess costs of medical
 67   II,     5.  5.Int(11)|                               Austbury J. (2002): Mental Health:
 68   II,     5.  5.  1    |               1.6. References~ ~Alonso J, Angermeyer MC, Bernert
 69   II,     5.  5.  1    |            suppl 420): 21-27.~ ~Alonso J, Angermeyer M, Bernert S, Bru t (
 70   II,     5.  5.  1    |             suppl 420):47-54.~ ~Alonso J, Lépine JP (2007). Overview
 71   II,     5.  5.  1    |              Mentl Disorders (ESEMeD). J Clin Psychiatry 68(suppl
 72   II,     5.  5.  1    |              TA, Collings SC, Atkinson J (2003). Unemployment and
 73   II,     5.  5.  1    |              for a causal association? J Epidemiol Community Health
 74   II,     5.  5.  1    |           Kovess V, Kessler RC, Alonso J and the ESEMED/MHEDEA Investigators (
 75   II,     5.  5.  1    |        National Comorbidity Survey. Br J Psychiatry 168(Suppl. 30):
 76   II,     5.  5.  1    |               Kovess-Masféty V, Alonso J, Brugha TS, Angermeyer MC,
 77   II,     5.  5.  1    |               from 3 European studies. J Clin Psychiatry 68(Suppl
 78   II,     5.  5.  1    |             review of the evidence. Am J Psychiatry 159(6):909-16.~ ~
 79   II,     5.  5.  1    |      Psychiatry 159(6):909-16.~ ~Ormel J, Petukhova M, Chaterji S, Agu C (
 80   II,     5.  5.  1    |              Mental Health Surveys. Br J Psychiatry 192(5):368-75.~ ~O A (
 81   II,     5.  5.  1    |                 Systematic review. Bri J Psychiatry 181:193-9.~ ~T G (
 82   II,     5.  5.  1    |               of depression in Europe. J Mental Health Policy Econ
 83   II,     5.  5.  1    |                a systematic review. Am J Med 118(4):330-41.~ ~Värnik
 84   II,     5.  5.  1    |          Alliance Against Depression". J Epidemiol Community Health.
 85   II,     5.  5.  2    |               31~ ~Godfrey M, Townsend J, Surr C, Boyle G and Brooker
 86   II,     5.  5.  3    |              Castillo M, Dallongeville J, Gilbert CC, Bergman P,
 87   II,     5.  5.  3    |         Jönsson B, Wittchen HU, Olesen J (2005): Cost of disorders
 88   II,     5.  5.  3    |               the brain in Europe. Eur J Neurol 12 Suppl 1:1-27.~
 89   II,     5.  5.  3    |               disorders in Europe. Eur J Neurol 12 Suppl 1:74-77.~
 90   II,     5.  5.  3    |         Andrews G, Sandersson K, Corry J, Issakidis C, Lapsley H (
 91   II,     5.  5.  3    |        treatment for schizophrenia. Br J Psychiatry 183:427-435.~
 92   II,     5.  5.  3    |                Decker P, Klosterkötter J, Maier W, Möller HJ, Gaebel
 93   II,     5.  5.  3    |     schizophrenia, A meta-analysis. Br J Psychiatry 171:502-8.~Buizza
 94   II,     5.  5.  3    |     population-based controlled study.~J Gen Intern Med 21(11):1133-
 95   II,     5.  5.  3    |                with schizophrenia. Can J Psychiatry 46:549-55.~Demyttenaere
 96   II,     5.  5.  3    |             Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine
 97   II,     5.  5.  3    |              Lara C, de Graaf R, Ormel J, Gureje O, Shen Y, Huang
 98   II,     5.  5.  3    |              Huang Y, Zhang M, Alonsro J, Haro JM, Vilagut G, Bromet
 99   II,     5.  5.  3    |        Association 291:25812590.~Engl J, Tschoner A, Laimer M, Rettenbacher
100   II,     5.  5.  3    |           services for their patients? J Ment Health Policy Econ
101   II,     5.  5.  3    |          epidemiological study. Nordic J. of Psychiatry 61(4):252-
102   II,     5.  5.  3    |              Baumann AE, Klosterkötter J, Maier W, Decker P, Möller
103   II,     5.  5.  3    |               survey and comparison Br J Psychiatry 187: 248-255.~
104   II,     5.  5.  3    |              Bechdolf A, Klosterkötter J, Wagner M, Maier W, Bottlender
105   II,     5.  5.  3    |                understanding the link? J Psychopharmacol 19: 56-65.~
106   II,     5.  5.  3    |               D, Makikyro T, Suvisaari J, Peltonen L, Lonnqvist J (
107   II,     5.  5.  3    |               J, Peltonen L, Lonnqvist J (1997): Schizophrenia in
108   II,     5.  5.  3    |               JK, Galderisi S, Libiger J, Hummer M, Dollfus S, Lopez-Ibor
109   II,     5.  5.  3    |               M, Dollfus S, Lopez-Ibor J, Hranov LG, Gaebel W, Peuskens
110   II,     5.  5.  3    |          Hranov LG, Gaebel W, Peuskens J, Lindefors N, Richer-Rössler
111   II,     5.  5.  3    |               1085-1097.~Klosterkötter J (2007): Prevention in Psychiatry: “
112   II,     5.  5.  3    |               4:172-173.~Klosterkötter J, Ruhrmann S, Schultze-Lutter
113   II,     5.  5.  3    |           review of recent literature. J Clin Psychiatry 63(10):892-
114   II,     5.  5.  3    |                S, Burkard T, Henderson J, Maj M, Sartorius N (2007):
115   II,     5.  5.  3    |               guidelines institute. Br J Psychiatry 188:193.~Lindström
116   II,     5.  5.  3    |             193.~Lindström E, Eberhard J, Neovius M, Levander S (
117   II,     5.  5.  3    |                33-40.~Lysaker PH, Tsai J, Yanos P, Roe D (2007):
118   II,     5.  5.  3    |               Bengtsson-Tops A, Dybbro J, Nilsson LL, Sandlund M,
119   II,     5.  5.  3    |            Kuipers E, Garety P, Geddes J, Orbach G, Morgan C (2002):
120   II,     5.  5.  3    |                 Pitschel-Walz G, Bäuml J (2007): Psychotherapie bei
121   II,     5.  5.  3    |               Saxena S, Maj M, Maselko J, Phillips MR, Rahman A (
122   II,     5.  5.  3    |               Saha S, Chant D, McGrath J (2005): A systematic review
123   II,     5.  5.  3    |              Saha S, Chant D, McGrrath J (2007): A systematic review
124   II,     5.  5.  3    |               depot antipsychotics. Br J Psychiatry 153:214-7.~Spollen
125   II,     5.  5.  3    |                Häfner H, Klosterkötter J, Maier W, Möller HJ, Gaebel
126   II,     5.  5.  3    |              in a rural town. Aust N Z J Psychiatry.39(6):514-21.~ ~
127   II,     5.  5.  3    |              Knapp M, Romeo R, Beecham J (2007): The economic consequences
128   II,     5.  5.  3    |            greater flexibility. Br Med J 331:60-61.~Beilmann A, Napa
129   II,     5.  5.  3    |               253-267.~Blom S, Heijbel J, Bergfors PG (1978): Incidence
130   II,     5.  5.  3    |             prevalence, and prognosis. J Neurol Neurosurg Psychiatry
131   II,     5.  5.  3    |               a systematic review. Eur J Neurol 12:245-253.~Fraser
132   II,     5.  5.  3    |         disorders. A meta-analysis. Br J Psychiatry 170:205-228.~
133   II,     5.  5.  3    |               205-228.~Jacoby A, Gorry J, Gamble C, Baker GA (2004):
134   II,     5.  5.  3    |        prospectively over 11-14 years. J Neurol Neurosurg Psychiatry
135   II,     5.  5.  3    |        Epilepsia 42:1025-1030.~Loiseau J, Loiseau P, Guyot M, et
136   II,     5.  5.  3    |          Epilepsia 31:391-396.~Loiseau J, Picot MC, Loiseau P (1999):
137   II,     5.  5.  3    |               associated health usage. J Neurol Neurosurg Psychiatry
138   II,     5.  5.  3    |              sudden death in epilepsy. J Neurol Neurosurg Psychiatry
139   II,     5.  5.  3    |               L, Blomquist HK, Heijbel J (1993): A community-based
140   II,     5.  5.  3    |       Sidenvall R, Forsgren L, Heijbel J (1996): Prevalence and characteristics
141   II,     5.  5.  3    |           onset in childhood. New Engl J Med 338:1715-1722.~Smeets
142   II,     5.  5.  3    |               Behav 10:354-362.~Taylor J, Chadwick D, Johnson T (
143   II,     5.  5.  3    |              in drivers with epilepsy. J Neurol Neurosurg Psychiatry
144   II,     5.  5.  3    |                Battaglia M, Kesselring J, Ketelaer P, Thompson A
145   II,     5.  5.  3    |             Mures County, Romania. Rom J Neurol Psychiatry 32:115-
146   II,     5.  5.  3    |             Bencsik K, Rajda C, Füvesi J, et al (2001): The prevalence
147   II,     5.  5.  3    |            Neurol 46:206-209.~Benedikz J, Magnus S, Guðmundsson J
148   II,     5.  5.  3    |               J, Magnus S, Guðmundsson J et al (2002): The natural
149   II,     5.  5.  3    |               104:208-210.~Benito-Léon J, Martín E, Vela L et al (
150   II,     5.  5.  3    |            among Danes with MS. Int MS J 13:66-71.~Buehler JW. Surveillance (
151   II,     5.  5.  3    |             over a 25-year period. Eur J Neurol 8:463-469.~Confavreux
152   II,     5.  5.  3    |                for multiple sclerosis. J Neurol Neurosurg Psychiatr
153   II,     5.  5.  3    |             multiple sclerosis. N Engl J Med 343:1430–1438.~Confavreux
154   II,     5.  5.  3    |               Scand 109:378-384.~DeJ, Paulos A, Mendes H, et
155   II,     5.  5.  3    |        District of Santarem, Portugal. J Neurol 253:914-918.~Dean
156   II,     5.  5.  3    |              Malta in 1999: an update. J Neurol Neurosurg Psychiatry
157   II,     5.  5.  3    |             trends, and prospects. Eur J Neurol 11:511–520~EUROPA.
158   II,     5.  5.  3    |                gradients really exist? J Neurol 246:1033–1040.~Ford
159   II,     5.  5.  3    |                Leeds Health Authority. J Neurol Neurosurg Psychiatry
160   II,     5.  5.  3    |           multiple sclerosis in Leeds. J Neurol 249:260-265.~Fox-Rushby
161   II,     5.  5.  3    |                indigeneous population. J Neurol 247;129-133.~Haffenden
162   II,     5.  5.  3    |               in Northern Ireland, UK. J Neurol Neurosurg Psychiatry
163   II,     5.  5.  3    |           effect of genetic diversity. J Neurol Neurosurg Psychiatry
164   II,     5.  5.  3    |          Multiple sclerosis in Cyprus. J Neurol Sci 103:29-36.~Milanov
165   II,     5.  5.  3    |               307~Miller D, Noseworthy J, Compston A (2006): Care
166   II,     5.  5.  3    |             province of Teruel, Spain. J Neurol 244:182-185.~Mor
167   II,     5.  5.  3    |             Multiple sclerosis. N Engl J Med 343;938-952.~Peterlin
168   II,     5.  5.  3    |           Peterlin B, Ristic S, Sepcic J, et al (2006): Region with
169   II,     5.  5.  3    |               in Croatia and Slovenia. J Neurol Sci 247:169-172.~
170   II,     5.  5.  3    |               sclerosis in Europe. Eur J Neurol 13: 700722.~Pugliatti
171   II,     5.  5.  3    |               392.~Robertson NP, Deans J, Fraser M, Compston DAS (
172   II,     5.  5.  3    |              districts of East Anglia. J Neurol Neurosurg Psychiatry
173   II,     5.  5.  3    |                genetic predisposition. J Neurol Neurosurg Psychiatry
174   II,     5.  5.  3    |               a critical overview. Can J Neurol Sci 20:17-29.~Sarasoja
175   II,     5.  5.  3    |               29.~Sarasoja T, Wikström J, Paltamaa J, et al (2004):
176   II,     5.  5.  3    |                T, Wikström J, Paltamaa J, et al (2004): Occurrence
177   II,     5.  5.  3    |               ML, Tienari PJ, Wikström J, Palo, J, Hakama M (2000):
178   II,     5.  5.  3    |          Tienari PJ, Wikström J, Palo, J, Hakama M (2000): Regional
179   II,     5.  5.  3    |               ML, Tienari PJ, Wikström J, Palo, J, Hakama M (2001):
180   II,     5.  5.  3    |          Tienari PJ, Wikström J, Palo, J, Hakama M (2001): Increasing
181   II,     5.  5.  3    |         Tienari PJ, Hakama M, Wikström J (2003): Multiple sclerosis
182   II,     5.  5.  3    |           progressive disease courses. J Neurol Neurosurg Psychiatry
183   II,     5.  5.  3    |             County in northern Sweden. J Neurol Neurosurg Psychiatry
184   II,     5.  5.  3    |             County in northern Sweden. J Neurol Neurosurg Psychiatry
185   II,     5.  5.  3    |            Valladolid, northern Spain. J Neurol 246:170-174.~Totaro
186   II,     5.  5.  3    |               district, central Italy. J Neurol Neurosurg Psychiat
187   II,     5.  5.  3    |                352.~Trapp BD, Peterson J, Ransohoff RM, et al (1998):
188   II,     5.  5.  3    |             multiple sclerosis. N Engl J Med 338:278-285.~Trisolini
189   II,     5.  5.  3    |               285.~Trisolini M, Wiener J, Miller D (2002): Principles
190   II,     5.  5.  3    |           sclerosis in French farmers. J Neurol Neurosurg Psychiatry
191   II,     5.  5.  3    |   population-based, prospective study. J Am Geriatr Soc 48(8):938-
192   II,     5.  5.  3    |         Jonsson B, Wittchen HU, Olesen J (2005): Cost of disorders
193   II,     5.  5.  3    |               the brain in Europe. Eur J Neurol 12 Suppl 1:1-27.~
194   II,     5.  5.  3    |                 1358-1363.~Benito-Leon J, Bermejo-Pareja F, Rodriguez
195   II,     5.  5.  3    |            Bermejo-Pareja F, Rodriguez J, Molina JA, Gabriel R, Morales
196   II,     5.  5.  3    |                Parkinson’s disease. Br J Clin Pract 49(6):288-293.~
197   II,     5.  5.  3    |               293.~Claveria LE, Duarte J, Sevillano MD, Perez-Sempere
198   II,     5.  5.  3    |           Rodriguez F, de Pedro-Cuesta J (2002): Prevalence of Parkinson’
199   II,     5.  5.  3    |                in Parkinson's disease. J Neurol Sci. 262:37-44.~Errea
200   II,     5.  5.  3    |               Aibar C, de Pedro-Cuesta J (1999): Prevalence of Parkinson’
201   II,     5.  5.  3    |              Beech C, Bowman C, Holmes J, Kingdom WK, MacMahon DG,
202   II,     5.  5.  3    |               for Parkinson’s disease. J Neurol Sci 217(2):169-174.~
203   II,     5.  5.  3    |               Parkinson’s disease. Eur J Neurol 13(11):1170-1185.~
204   II,     5.  5.  3    |               s disease in Europe. Eur J Neurol 12 Suppl 1:68-73.~
205   II,     5.  5.  3    |                a Scottish city. Br Med J 292(6519):534-536.~Nath
206   II,     5.  5.  3    | Steele-Richardson-Olszewski syndrome). J Neurol Neurosurg Psych 76(
207   II,     5.  5.  3    |                568.~Riedel O, Klotsche J, Spottke A, Deuschl G, Forstl
208   II,     5.  5.  3    |                of Parkinson’s disease. J Chronic Dis 26(4):243-254.~
209   II,     5.  5.  3    |                Koehne-Volland R, Rieke J, Simonow A, Brandstaedter
210   II,     5.  5.  3    |               multiple system atrophy. J Neural Transm 112(12):1605-
211   II,     5.  5.  3    |            family, and the individual. J Am Geriatr Soc 45(7):844-
212   II,     5.  6.  6    |  Epidemiological aspects of back pain. J Soc Occup Med 36:90-94~Andersson
213   II,     5.  6.  6    |                pain localization. Clin J Pain 9:174-182~Arnett FC,
214   II,     5.  6.  6    |            1990 Ontario Health Survey. J Rheumatol 21:505-514~Badley
215   II,     5.  6.  6    |              Swedish population study. J Rheumatol 28:1369-1377~Birnbaum
216   II,     5.  6.  6    |              Arthritis to an Employer. J Occup Environ Med 42(6):
217   II,     5.  6.  6    |               absence in Norway. Scand J Soc Med 26:34-43~Brooks
218   II,     5.  6.  6    |            Nielsen H, Silman A, Smolen J, Yazici H (2007): EULAR
219   II,     5.  6.  6    |          impact on quality of life. Am J Med 103:12S-17S~Cooper C,
220   II,     5.  6.  6    |             osteoporotic fractures. Am.J Epidemiol 137:1001-1005~
221   II,     5.  6.  6    |              Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995):
222   II,     5.  6.  6    |       Fractures Research Group. N Engl J Med 332:767-773~Davis MA,
223   II,     5.  6.  6    |    distribution and osteoarthritis. Am J Epidemiol 132:701-707~Department
224   II,     5.  6.  6    |            osteoarthritis of the knee. J Rheumatol 19:378-384~EULAR
225   II,     5.  6.  6    |             osteoporosis study (EPOS). J Bone Miner Res 17:716-724~
226   II,     5.  6.  6    |              pain and sciatica. N Engl J Med 318:291-300~Hagen KB,
227   II,     5.  6.  6    |        arthritis: a population survey. J Rheumatol 24:1703-1709~Hakala
228   II,     5.  6.  6    |       retention of functional ability. J Rheumatol 21:1432-1437~Hochberg
229   II,     5.  6.  6    |        Schulenburg JM, Zeidler H, Ruof J (2005): Direct Costs Related
230   II,     5.  6.  6    |             Technology Assessment. Int J Technol Assess Health Care
231   II,     5.  6.  6    |              Juni P, Dieppe P, Donovan J, Peters T, Eachus J, Pearson
232   II,     5.  6.  6    |            Donovan J, Peters T, Eachus J, Pearson N, Greenwood R,
233   II,     5.  6.  6    | gatekeeper-model managed care plan. Am J Manag Care 6:669-678~Linos
234   II,     5.  6.  6    |          prevalence, and mortality. Am J Epidemiol 111:87-98~Lock
235   II,     5.  6.  6    |                Washington DC~Magaziner J, Simonsick EM, Kashner TM,
236   II,     5.  6.  6    |         fracture: a prospective study. J Gerontol 45:M101-M107~Meerding
237   II,     5.  6.  6    |                the general population. J Bone Miner Res 18:1139-1141~
238   II,     5.  6.  6    |              in a local community. Eur J Gen Pract 1:25-28~Naz SM
239   II,     5.  6.  6    |                Shen W, Cooper C, Kanis J (2000): Health-related quality
240   II,     5.  6.  6    |         prevalent vertebral fractures. J Bone Miner Res 15:1384-1392~
241   II,     5.  6.  6    |               the Dutch population. Am J Public Health 87:1680-1682~
242   II,     5.  6.  6    |              musculoskeletal diseases. J Rheumatol 19:1020-1030~Sernbo
243   II,     5.  6.  6    |                poorer quality of life? J Clin Epidemiol 53:895-907~
244   II,     5.  6.  6    |            Stansfeld S, Feeney A, Head J, Canner R, North F, Marmot
245   II,     5.  6.  6    |              57:649-655~Van den Velden J, De Bakker DH, Claessens
246   II,     5.  7.  7    |                1):e382-e387.~Atthobari J, Asselbergs FW, Boersma
247   II,     5.  7.  7    |              the AusDiab kidney study. J Am Soc Nephrol 2003;14(7
248   II,     5.  7.  7    |               Suppl 2):S131-S138.~Chen J, Wildman RP, Gu D, Kusek
249   II,     5.  7.  7    |                Aug;70(4):800-6.~Coresh J, Byrd-Holt D, Astor BC,
250   II,     5.  7.  7    |             U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005 Jan;
251   II,     5.  7.  7    |           Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O (
252   II,     5.  7.  7    |             for chronic renal failure. J Am Soc Nephrol 2006 Jun;
253   II,     5.  7.  7    |                11(4):438-42.~Fadrowski J, Cole SR, Hwang W, Fiorenza
254   II,     5.  7.  7    |             Cole SR, Hwang W, Fiorenza J, Weiss RA, Gerson A, et
255   II,     5.  7.  7    |                hospitalization. N Engl J Med 2004 Sep 23;351(13):
256   II,     5.  7.  7    |              2801-8.~Hallan SI, Coresh J, Astor BC, Asberg A, Powe
257   II,     5.  7.  7    |              prevalence and ESRD risk. J Am Soc Nephrol 2006; 17:
258   II,     5.  7.  7    |     Grootendorst DC, Aasberg A, Holmen J, et al (2006b): Screening
259   II,     5.  7.  7    |              among nondiabetic adults. J Am Soc Nephrol 2005 Jul;
260   II,     5.  7.  7    |              2001;16 Suppl 7:57-60~Lin J, Knight EL, Hogan ML, Singh
261   II,     5.  7.  7    |                without kidney disease. J Am Soc Nephrol 2003 Oct;
262   II,     5.  7.  7    |                long-term implications. J Am Soc Nephrol 2002;13(Suppl
263   II,     5.  7.  7    |          general population. Eur Heart J 2006 May;27(10):1245-50.~
264   II,     5.  7.  7    |             chronic kidney disease. Am J Kidney Dis 2006;47(Suppl
265   II,     5.  7.  7    |  classification and stratification. Am J Kidney Dis 2002;39(Supple
266   II,     5.  7.  7    |             chronic kidney disease. Am J Kidney Dis 2003;41(suppl
267   II,     5.  7.  7    |             chronic kidney disease. Am J Kidney Dis 2003;42(Suppl
268   II,     5.  7.  7    |             chronic kidney disease. Am J Kidney Dis 2004;43(Suppl
269   II,     5.  7.  7    |               an evolving reality. Int J Health Care Finance Econ
270   II,     5.  7.  7    |                 Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et
271   II,     5.  7.  7    |             Survey (NHANES) 1999-2002. J Gen Intern Med 2007 Jul;
272   II,     5.  7.  7    |                a large HMO population. J Am Soc Nephrol 2004 May;
273   II,     5.  7.  7    |             risk: a systematic review. J Am Soc Nephrol 2006 Jul;
274   II,     5.  8.  7    |               1164/ rccm.167.5.787. Am.J.Resp.Crit.Care Med. 167(
275   II,     5.  8.  7    |              167(5): 787-797.~ ~Balmes J, Becklake M, Blanc P, Henneberger
276   II,     5.  8.  7    |          Burden of Airway Disease. Am. J. Respir. Crit. Care Med.
277   II,     5.  8.  7    |              inorganic dust~Eur Respir J 23: 402-406.~ ~Bilde L,
278   II,     5.  8.  7    |               Rud Svenning A, Dollerup J, Baekke Borgeskov H, Lange
279   II,     5.  8.  7    |       Respiratory Diseases.~Eur Respir J 2007; 29: 233-239.~ ~Boutin-Forzano
280   II,     5.  8.  7    |           pan-European estimation. Int J Tuberc Lung Dis 2007; 11:
281   II,     5.  8.  7    |             position paper. Eur Respir J 2004; 23: 932-946.~ ~Cerveri
282   II,     5.  8.  7    |               young adults. Eur Respir J 2003; 22: 413-417.~ ~Chapman
283   II,     5.  8.  7    |          pulmonary disease. Eur Respir J 2006; 27: 188-207.~ ~Dal
284   II,     5.  8.  7    |           Cerveri I, Corsico A, Sunyer J, Neukirch F, Kunzli N, Leynaert
285   II,     5.  8.  7    |      obstructive pulmonary disease. Am J Respir Crit Care Med 2003;
286   II,     5.  8.  7    |          Furhman C, Jougla E, Nicolauu J, Eilstein D, Delmas M-C (
287   II,     5.  8.  7    |                   Goodridge D., Lawson J., Duggleby W.,Marciniuk
288   II,     5.  8.  7    |            Goljan-Geremek A, Zielinski J (2003): Diagnosis of airflow
289   II,     5.  8.  7    |           implications for management. J Nurs Manag. 2008 Mar; 16(
290   II,     5.  8.  7    |              meta-analysis. Eur Respir J 2006; 28: 523-532.~ ~Hansell
291   II,     5.  8.  7    |            coding analysis. Eur Respir J 2003; 22: 809-814.~ ~Jansson
292   II,     5.  8.  7    |          general adult population. Int J Tuberc Lung Dis 2005; 9:
293   II,     5.  8.  7    |    Longitudinal Aging Study Amsterdam. J Clin Epidemiol 2004; 57:
294   II,     5.  8.  7    |       Scharling H, Fabricius P, Vestbo J (2006): Developing COPD:
295   II,     5.  8.  7    |                Europe: FP7. Eur Respir J 2007; 29: 223-225.~ ~Mannino
296   II,     5.  8.  7    |         disease (COPD). A review. Nord J Psychiatry 2004; 58: 65-
297   II,     5.  8.  7    |                M, de la Roza C, Morera J, Montemayor T, Gobartt E,
298   II,     5.  8.  7    |             what's the difference? Eur J Public Health 2006; 16:
299   II,     5.  8.  7    |           Murtagh E, Heaney L, Gingles J, Shepherd R, Kee F, Patterson
300   II,     5.  8.  7    |               F, Patterson C, MacMahon J (2005): Prevalence of obstructive
301   II,     5.  8.  7    |                the NICECOPD study. Eur J Epidemiol 2005; 20: 443-
302   II,     5.  8.  7    |          pulmonary disease. Intern Med J 2004;34(11):608-14~ ~ ~Schirnhofer
303   II,     5.  8.  7    |             Visick G, Thakrar B, Sykes J, Pride NB (2000): Recent
304   II,     5.  8.  7    |                aged 40 to 55 years. Br J Gen Pract 2004; 54: 201-
305   II,     5.  8.  7    |            2004; 54: 201-206.~ ~Sunyer J, Zock JP, Kromhout H, Garcia-Esteban
306   II,     5.  8.  7    |          Exposures in Young Adults Am. J. Respir. Crit. Care Med.
307   II,     5.  8.  7    |            history of COPD. Eur Respir J 2007; 30: 993–1013~ ~Vrbica
308   II,     5.  8.  7    |                smoking cigarettes. Eur J Epidemiol 2004; 19: 147-
309   II,     5.  8.  7    |                19: 147-53.~ ~Zielinski J, Bednarek M, Gorecka D,
310   II,     5.  8.  7    |             COPD awareness. Eur Respir J 2006; 27: 833-852.~ ~Zock
311   II,     5.  8.  7    |                852.~ ~Zock J-P, Sunyer J, Kogevinas M, Kromhout H,
312   II,     5.  8.  7    |                International Study Am. J. Respir. Crit. Care Med.
313   II,     5.  9. FB    |               FB.9. References~ ~Plumb J, Brawer R, Brisbon N (2007):
314   II,     5.  9.  7    |            costs of asthma. Eur Respir J. 2006 Apr;9(4):636-42~ ~Bj P (
315   II,     5.  9.  7    |                Pt 1):585-92~ ~Bousquet J (2003): Allergic Rhinitis
316   II,     5.  9.  7    |              Health Survey. Eur Respir J, 1994, 7, 954-960~ ~Compalati
317   II,     5.  9.  7    |             Allergy Clin Immunol IntJ World Allergy Org; 19:82-
318   II,     5.  9.  7    |          inhalant allergens in adults. J Allergy Clin Immunol. 2003
319   II,     5.  9.  7    |            history of asthma in Italy. J Allergy Clin Immunol. 2002
320   II,     5.  9.  7    |         Steering Committee. Eur Respir J 2002; 20:1071-1079~ ~Fasce
321   II,     5.  9.  7    |          Available at: www ~ ~Heinrich J Gehring U, , Jacob B, Richter
322   II,     5.  9.  7    |            Luczynska C, Chinn S, Potts J, Stunyer J, Janson C, Svanec
323   II,     5.  9.  7    |              Chinn S, Potts J, Stunyer J, Janson C, Svanec C, Kunzly
324   II,     5.  9.  7    |                historical perspective. J Laryngol Otol. Dec;117(12):
325   II,     5.  9.  7    |             PhyCor experience. Jt Comm J Qual Improv. 1999 Feb;25(
326   II,     5.  9.  7    |              60-5~ ~Schipper H, Clinch J, Olweny CLM (1990): Quality
327   II,     5.  9.  7    |              detection, and diagnosis. J Allergy Clin Immunol. 2001
328   II,     5.  9.  7    |                RHINE study. Eur Respir J 2004; 24: 942-946~ ~To E,
329   II,     5.  9.  7    |           Results of an Italian study. J Allergy Clin Immunol. 2003
330   II,     5.  9.  7    |                environmental antigens. J Allergy Clin Immunol. 2006
331   II,     5. 10.  7    |       Hoffmann-Sommergruber K, Lidholm J, Mustakov T, Oude Elberink
332   II,     5. 10.  7    |               Kosunen TU, Hook-Nikanne J, Salomaa A, Sarna S, Aromaa
333   II,     5. 10.  7    |               T, Goldhahn K, Dahlstrom J (2007): The prevalence of
334   II,     5. 10.  7    |              allergy: A meta-analysis. J Allergy Clin Immunol 120,
335   II,     5. 10.  7    |                in coeliac disease. Eur J Gastroenterol Hepatol 13:
336   II,     5. 10.  7    |               A, Crevel R, Fitzpatrick J, Mills C, Privalle L, Vieths
337   II,     5. 10.  7    |               young adults. Eur Respir J 1998; 11(1):151-155.~ ~Woods
338   II,     5. 10.  7    |          Survey (ECRHS) 1991-1994. Eur J Clin Nutr 2001; 55(4):298-
339   II,     5. 10.  7    |             Woods RK, Stoney RM, Raven J, Walters EH, Abramson M,
340   II,     5. 10.  7    |          allergy in the community. Eur J Clin Nutr; 56(1):31-36.~ ~
341   II,     5. 11.  3    |            skin diseases in Europe Eur J Dermatol 2006;16:212-218~ ~ ~
342   II,     5. 11.  7    |   clinicopathological characteristics. J Dermatol 2003;30:123131.~ ~
343   II,     5. 11.  7    |             for population surveys. Br J Dermatol 2003;149:794-800.~ ~
344   II,     5. 11.  7    |          decreases in Scandinavia. Int J Cancer 2003;107:119126.~ ~
345   II,     5. 11.  7    |        epidemiology of skin cancer. Br J Dermatol 2002;146(S61):1-
346   II,     5. 11.  7    |            2002;146(S61):1-6.~ ~Ferlay J, Bray F, Pisani P, Parkin
347   II,     5. 11.  7    |                from a European survey. J Eur Acad Dermatol Venereol
348   II,     5. 11.  7    |      Literature review. Onychomycosis. J Eur Acad Dermatol Venereol.
349   II,     5. 11.  7    |          hospital-based assessment. Br J Dermatol 1994;131(S44):34.~ ~
350   II,     5. 11.  7    |            Statistics 1978: 172~ ~Kay J, Gawkrodger DJ, Mortimer
351   II,     5. 11.  7    |               in a general population. J Am Acad Dermatol 1994;30:
352   II,     5. 11.  7    |              an update, 19761998. Eur J Cancer Prev 2001;10:371–
353   II,     5. 11.  7    |                  Neame RL, Berth-Jones J, Kurinczuk JJ et al (1995):
354   II,     5. 11.  7    |          possible ethnic variation. Br J Dermatol 1995;132:772-7.~ ~
355   II,     5. 11.  7    |              use of medical care. Brit J Prev Soc Med 1976;30:107–
356   II,     5. 11.  7    |          Disability in Dermatology. Br J Hosp Med 1991;46:336.~ ~
357   II,     5. 11.  7    |           atopic eczema eds T Ruzicka, J Ring, B Pryzbilla). London:
358   II,     5. 11.  7    |            EDEN hand-eczema survey. Br J Dermatol 2004;151(2):446-
359   II,     5. 11.  7    |           international comparison. Br J Dermatol 2002;147:716-24.~ ~
360   II,     5. 11.  7    |           onychomycosis in Britain. Br J Dermatol 1993;129:101-109.~ ~
361   II,     5. 11.  7    |              of the advantaged? Br Med J 1994;308:1132-35.~ ~Williams
362   II,     5. 11.  7    |              for atopic dermatitis. Br J Dermatol (1994b):131:383-
363   II,     5. 11.  7    |             risk of atopic dermatitis. J Am Acad Dermatol 1995;32:
364   II,     5. 11.  7    |                 In: Stevens A, Raftery J, eds. Health Care Needs
365   II,     5. 11.  7    |            skin diseases in Europe Eur J Dermatol 2006:16:212-218.~ ~ ~ ~
366   II,     5. 12.  7    |              1988 through 1994. N Engl J Med 341:556-562.~ ~Armstrong
367   II,     5. 12.  7    |          cirrhosis: an update to 2002. J Hepatol 46:827-839.~Chu
368   II,     5. 12.  7    |               alcohol consumption. Int J Epidemiol 26:100-109.~ ~
369   II,     5. 12.  7    |                103:385-389.~de la Pena J, Brullet E, Sanchez-Hernandez
370   II,     5. 12.  7    |            Martin -~ ~Ioannou G, Doust J, Rockey DC (2003): Terlipressin
371   II,     5. 12.  7    |                benefits and risks. Int J Vitam Nutr Res 71:210-213.~ ~
372   II,     5. 12.  7    |                   Leon DA, McCambridge J (2006): Liver cirrhosis
373   II,     5. 12.  7    |               a systematic review. Int J Cancer 111:1-8.~ ~Poynard
374   II,     5. 12.  7    |          survival. Multi-centre group. J Hepatol 30:1130-1137.~ ~
375   II,     5. 12.  7    |            S19-33.~ ~Sauer P, Hansmann J, Richter GM, Stremmel W,
376   II,     5. 15.  6    |          orphan medicinal products. Br J Clin Pharmacol 2006, 62:
377   II,     5. 15.  6    |              Kanavos P, Ubel P, Rovira J (2007): Assessing the economic
378   II,     5. 15.  6    |             posed by orphan drugs. Int J Technol Assess Health Care.
379   II,     5. 15.  6    |         treating rare diseases. N Engl J Med. 2006 Feb 2;354(5):445-
380   II,     5. 15.  6    |               online version, OMIM. Am J Hum Genet, 80: 588-604,
381   II,     5. 15.  6    |        rare diseases and orphan drugs. J Intern Med. 2006; 260(1):
382   II,     7.  7        |           Board.~ ~MacKay M, Vincenten J, Brussoni M, Towner L (2006):
383   II,     7.  7        |                 MacKay M and Vincenten J (2007): Child Safety Summary
384   II,     8.  2.  1    |                Cooper, S.-A. Morrison, J., Melville, C. Finlayson,
385   II,     8.  2.  1    |                Melville, C. Finlayson, J., Allan, L., Martin, G.
386   II,     8.  2.  1    |                Fujiura, G.T., Park, H. J. and Rutkowski-Kmitta, V. (
387   II,     8.  2.  1    |        Accessed 17 October 2008~Mason, J., & Scior, K., (2004). Diagnostic
388   II,     8.  2.  1    |                42 (4), 264-272.~Rimmer,J.H. (1999). health promotion
389   II,     8.  2.  1    |               E., Spreat, S., Tasse, M.J., Thompson, J.R., Verdugo,
390   II,     8.  2.  1    |                 Tasse, M.J., Thompson, J.R., Verdugo, M-A, Wehmeyer,
391   II,     8.  2.  1    |             124.~Schultz, S., Shenkin, J., & Horowitz, A. (2001).
392   II,     8.  2.  1    |              Krahn G, Lennox N, Meaney J & Wehmeyer M (2005). Reducing
393   II,     8.  2.  1    |                4), 249-55.~Straetmans, J.M.J.A.A., H.M.J. van Schrojenstein
394   II,     8.  2.  1    |                249-55.~Straetmans, J.M.J.A.A., H.M.J. van Schrojenstein
395   II,     8.  2.  1    |            Straetmans, J.M.J.A.A., H.M.J. van Schrojenstein Lantman-de
396   II,     8.  2.  1    |               Valk, F.G. Schellevis, G.J. Dinant (2007). Health problems
397   II,     8.  2.  1    |              European perspective. Eur J Public Health 13: 47-50;
398   II,     8.  2.  3    |           Great Britain. International J Epidemiology. 1989;18:911-
399   II,     8.  2.  3    |               in Sweden. International J Audiology. 2003;42:18-28~ ~
400   II,     9.  1.  1    |                perinatal mortality. Am J Obstet Gynecol 2005;193(
401   II,     9.  1.  1    |                outcomes in Europe. Eur J Obstet Gynecol Reprod Biol
402   II,     9.  1.  1    |                 descriptive study. Eur J Obstet Gynecol Reprod Biol
403   II,     9.  1.  1    |                86(4 Pt 2):700-5.~ ~Bai J, Wong FW, Bauman A, Mohsin
404   II,     9.  1.  1    |             and pregnancy outcomes. Am J Obstet Gynecol 2002;186(
405   II,     9.  1.  1    |              on birth certificates. Am J Public Health 1992;82(2):
406   II,     9.  1.  1    |           Gissler M, Breart G, Zeitlin J (2006): Preterm birth and
407   II,     9.  1.  1    |         Medical Experts Committee. Eur J Obstet Gynecol Reprod Biol
408   II,     9.  1.  1    |              population in Europe. Eur J Obstet Gynecol Reprod Biol
409   II,     9.  1.  1    |               C, Guillem P, Fauconnier J, Rambaud P, Jouk PS (2003):
410   II,     9.  1.  1    |       Canterino JC, Ananth CV, Smulian J, Harrigan JT, Vintzileos
411   II,     9.  1.  1    |            gestations: USA, 1995-2000. J Matern Fetal Neonatal Med
412   II,     9.  1.  1    |                 Five meta-analyses. Am J Prev Med 1999;16(3):208-
413   II,     9.  1.  1    |                 208-15.~Cleary-Goldman J, Malone FD, Vidaver J, Ball
414   II,     9.  1.  1    |   Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock
415   II,     9.  1.  1    |             population-based study. Am J Obstet Gynecol 1993;168(
416   II,     9.  1.  1    |                in The Netherlands. Eur J Obstet Gynecol Reprod Biol
417   II,     9.  1.  1    |               retrospective study. Eur J Obstet Gynecol Reprod Biol
418   II,     9.  1.  1    |             with singleton infants. Am J Obstet Gynecol 2004;191(
419   II,     9.  1.  1    |               cesarean section. N Engl J Med 1989;321(4):233-9.~ ~
420   II,     9.  1.  1    |            vitro fertilization. N Engl J Med 2002;346(10):725-30.~ ~
421   II,     9.  1.  1    |            2002;346(10):725-30.~ ~Holt J, Vold IN, Odland JO, Forde
422   II,     9.  1.  1    |              Lorenz JM, Cleary-Goldman J, D'Alton ME, et al (2003):
423   II,     9.  1.  1    |             Kramer MS, Seguin L, Lydon J, Goulet L (2000b): Socio-economic
424   II,     9.  1.  1    |                dans 8 pays differents. J Gynecol Obstet Biol Reprod (
425   II,     9.  1.  1    |                358-66.~ ~Langhoff-Roos J, Kesmodel U, Jacobsson B,
426   II,     9.  1.  1    |     birth weight and infant mortality. J Reprod Med 2004;49(10):812-
427   II,     9.  1.  1    |               2004;49(10):812-6.~Maher J, Macfarlane A (2004): Inequalities
428   II,     9.  1.  1    |             the risk of stillbirth. Br J Obstet Gynaecol 1994;101(
429   II,     9.  1.  1    |               in the United States. Am J Obstet Gynecol 2006;195(
430   II,     9.  1.  1    |               L, Levasseur M, Schenker J, et al (1993):~Patterns
431   II,     9.  1.  1    |               e815-25.~ ~van Roosmalen J, Schuitemaker NW, Brand
432   II,     9.  1.  1    |                 Bennebroek Gravenhorst J (2002): Substandard care
433   II,     9.  1.  1    |            EPICure Study Group. N Engl J Med 2000;343(6):378-84.~ ~
434   II,     9.  1.  1    |               343(6):378-84.~ ~Zeitlin J, Blondel B, Alexander S,
435   II,     9.  1.  1    |             114(9):1097-103.~ ~Zeitlin J, Wildman K, Breart G, Alexander
436   II,     9.  1.  1    |              the PERISTAT project. Eur J Obstet Gynecol Reprod Biol
437   II,     9.  1.  2    |               H, Erickson EJ, Halliday J, Irgens LM, Lowry RB, McDonnell
438   II,     9.  1.  2    |               RB, McDonnell R, Metneki J, Poetzsch S, Ritvanen A,
439   II,     9.  1.  2    |              population in Europe. Eur J Obstet Gynecol Repr Biol,
440   II,     9.  1.  2    |                Christiansen M, Goujard J, Steinbicker V, Roesch C,
441   II,     9.  1.  2    |         Cordier S, Bergeret A, Goujard J, Ha M-C, Ayme S, Bianchi
442   II,     9.  1.  2    |         Danaché B, De Vigan C, Fevotte J, Kiel G, Mandereau L, for
443   II,     9.  1.  2    |                Ha M-C, Aymé S, Goujard J (1992): "Maternal Occupational
444   II,     9.  1.  2    |      fortification in Canada. New Engl J Med 2007;357: 135-42.~Dolk
445   II,     9.  1.  2    |             441-447.~Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle
446   II,     9.  2.  7    |               Heuveline P., Timberlake J.M. (2000): Toward A Child-Centered
447   II,     9.  2.  7    |             279~ ~Lerner, R.M., Orlos, J.B., Knapp, J.R. (1976):
448   II,     9.  2.  7    |              R.M., Orlos, J.B., Knapp, J.R. (1976): Physical attractiveness,
449   II,     9.  2.  7    |              in Europe, 19551995. Eur J Cancer. 37:785-809.~ ~Masoli
450   II,     9.  3.  1    |         References~ ~Arber S, McKinlay J, Adams A, et al, (2006):
451   II,     9.  3.  1    |           Lodding P, Lilja H, Hugosson J (2007): Prostate Cancer
452   II,     9.  3.  1    |            Urol 51: 659-664~ ~Austbury J: (2002): Mental Health ‘
453   II,     9.  3.  1    |       Cambridge~ ~Aytac, I., McKinlay, J. & Krane, R. (1999) The
454   II,     9.  3.  1    |                study of vulvar cancer. J Natl Cancer Inst, 1997.
455   II,     9.  3.  1    |              148(9): 680-W137.~ ~Shah, J., (2002) Erectile dysfunction
456   II,     9.  3.  2    |                outcomes in Europe. Eur J Obstet Gynecol Reprod Biol
457   II,     9.  3.  2    |                 descriptive study. Eur J Obstet Gynecol Reprod Biol
458   II,     9.  3.  2    |                perinatal mortality. Am J Obstet Gynecol 2005;193(
459   II,     9.  3.  2    |             1995;86(4 Pt 2):700-5.~Bai J, Wong FW, Bauman A, Mohsin
460   II,     9.  3.  2    |             and pregnancy outcomes. Am J Obstet Gynecol 2002;186(
461   II,     9.  3.  2    |              on birth certificates. Am J Public Health 1992;82(2):
462   II,     9.  3.  2    |           Gissler M, Breart G, Zeitlin J (2006): Preterm birth and
463   II,     9.  3.  2    |         Medical Experts Committee. Eur J Obstet Gynecol Reprod Biol
464   II,     9.  3.  2    |              population in Europe. Eur J Obstet Gynecol Reprod Biol
465   II,     9.  3.  2    |               C, Guillem P, Fauconnier J, Rambaud P, Jouk PS (2003):
466   II,     9.  3.  2    |       Canterino JC, Ananth CV, Smulian J, Harrigan JT, Vintzileos
467   II,     9.  3.  2    |            gestations: USA, 1995-2000. J Matern Fetal Neonatal Med
468   II,     9.  3.  2    |                 Five meta-analyses. Am J Prev Med 1999;16(3):208-
469   II,     9.  3.  2    |               208-15.~ ~Cleary-Goldman J, Malone FD, Vidaver J, Ball
470   II,     9.  3.  2    |   Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock
471   II,     9.  3.  2    |             population-based study. Am J Obstet Gynecol 1993;168(
472   II,     9.  3.  2    |                in The Netherlands. Eur J Obstet Gynecol Reprod Biol
473   II,     9.  3.  2    |               retrospective study. Eur J Obstet Gynecol Reprod Biol
474   II,     9.  3.  2    |             with singleton infants. Am J Obstet Gynecol 2004;191(
475   II,     9.  3.  2    |               cesarean section. N Engl J Med 1989;321(4):233-9.~ ~
476   II,     9.  3.  2    |            vitro fertilization. N Engl J Med 2002;346(10):725-30.~ ~
477   II,     9.  3.  2    |            2002;346(10):725-30.~ ~Holt J, Vold IN, Odland JO, Forde
478   II,     9.  3.  2    |              Lorenz JM, Cleary-Goldman J, D'Alton ME, et al (2003):
479   II,     9.  3.  2    |             Kramer MS, Seguin L, Lydon J, Goulet L (2000): Socio-economic
480   II,     9.  3.  2    |                dans 8 pays differents.~J Gynecol Obstet Biol Reprod (
481   II,     9.  3.  2    |                358-66.~ ~Langhoff-Roos J, Kesmodel U, Jacobsson B,
482   II,     9.  3.  2    |     birth weight and infant mortality. J Reprod Med 2004;49(10):812-
483   II,     9.  3.  2    |             2004;49(10):812-6.~ ~Maher J, Macfarlane A (2004): Inequalities
484   II,     9.  3.  2    |             the risk of stillbirth. Br J Obstet Gynaecol 1994;101(
485   II,     9.  3.  2    |               in the United States. Am J Obstet Gynecol 2006;195(
486   II,     9.  3.  2    |          Schuitemaker N, van Roosmalen J, Dekker G, van Dongen P,
487   II,     9.  3.  2    |                 Bennebroek Gravenhorst J (1998): Confidential enquiry
488   II,     9.  3.  2    |             Netherlands 1983-1992. Eur J Obstet Gynecol Reprod Biol
489   II,     9.  3.  2    |               L, Levasseur M, Schenker J, et al (1993):~ ~Patterns
490   II,     9.  3.  2    |         Hannaford P, Cattaneo A, Olsen J, Bloemenkamp KW, et al (
491   II,     9.  3.  2    |             The REPROSTAT project. Eur J Obstet Gynecol Reprod Biol
492   II,     9.  3.  2    |               e815-25.~ ~van Roosmalen J, Schuitemaker NW, Brand
493   II,     9.  3.  2    |                 Bennebroek Gravenhorst J (2002): Substandard care
494   II,     9.  3.  2    |            EPICure Study Group. N Engl J Med 2000;343(6):378-84.~ ~
495   II,     9.  3.  2    |               343(6):378-84.~ ~Zeitlin J, Blondel B, Alexander S,
496   II,     9.  3.  2    |             114(9):1097-103.~ ~Zeitlin J, Wildman K, Breart G, Alexander
497   II,     9.  3.  2    |              the PERISTAT project. Eur J Obstet Gynecol Reprod Biol
498   II,     9.  3.  3    |          life-skill building (Shepherd J et al, 2000).~ ~
499   II,     9.  3.  3    |             behaviour in Portugal. Int J STD&AIDS 15:56-60~Bajos
500   II,     9.  3.  3    |               56-60~Bajos N, Wadsworth J, Ducot B, Johnson AM, Le